Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TIKOSYN for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 124 adverse event reports in the FDA FAERS database where TIKOSYN was used for Atrial fibrillation.

Most Reported Side Effects for TIKOSYN

Side Effect Reports % Deaths Hosp.
Drug ineffective 29 10.2% 0 3
Atrial fibrillation 23 8.1% 0 10
Cardiac disorder 18 6.3% 0 6
Malaise 17 6.0% 0 1
Drug interaction 15 5.3% 0 1
Fatigue 11 3.9% 0 0
Headache 11 3.9% 0 0
Death 10 3.5% 10 0
Diarrhoea 10 3.5% 0 0
Dyspnoea 9 3.2% 0 5
Heart rate increased 9 3.2% 0 1
Dizziness 8 2.8% 0 0
Electrocardiogram qt prolonged 8 2.8% 0 2
Muscle spasms 8 2.8% 0 0
Arrhythmia 7 2.5% 0 1

Other Indications for TIKOSYN

Atrial flutter (26) Arrhythmia (13) Product used for unknown indication (5)

Other Drugs Used for Atrial fibrillation

RIVAROXABAN (52,584) DABIGATRAN ETEXILATE (20,492) APIXABAN (10,500) AMIODARONE (9,083) WARFARIN (8,680) EDOXABAN (3,855) ASPIRIN (2,993) DOFETILIDE (2,439) PRADAXA (2,325) METOPROLOL (1,542)

Related Pages

TIKOSYN Full Profile All Atrial fibrillation Drugs TIKOSYN Demographics TIKOSYN Timeline